COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate Read more
SLAs to issue manufacture/sale licenses for AYUSH formulations only after approval from AYUSH Ministry Read more
CDSCO extends consent to import drugs with less than 60 per cent residual shelf life by three months Read more